West Nile Virus: FDA Clears PanBio Test, Canada Okays Roche Blood Screen

The de novo 510(k) route pursued by PanBio for its Capture West Nile virus clinical lab test could set a precedent for expedited approvals of diagnostics to detect emerging diseases

More from Archive

More from Medtech Insight